Last update 11 Oct 2025

Allogenic stem cells (Celavie Biosciences)

Overview

Basic Info

Drug Type
Neural stem cell therapy
Synonyms
hNPCs Celavie Biosciences, Human neural progenitor cell Celavie Biosciences, OK99 undifferentiated stem cells
+ [1]
Target-
Action-
Mechanism
Stem cell replacements
Therapeutic Areas
Nervous System DiseasesEndocrinology and Metabolic DiseaseOther Diseases
Active Indication-
Inactive Indication
Cerebellar AtaxiaEpilepsyParkinson Disease
Originator Organization
Celavie Biosciences LLCCelavie Biosciences LLC
Active Organization-
Inactive Organization
Celavie Biosciences LLCCelavie Biosciences LLCThe California State UniversityThe California State University
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Allogenic stem cells (Celavie Biosciences)
NCT02780895
/ Unknown statusPhase 1
Human OK99 Allogeneic Stem Cell Transplantation for Patients With Severe Parkinson's Disease
100 Clinical Results associated with Allogenic stem cells (Celavie Biosciences)
Login to view more data
100 Translational Medicine associated with Allogenic stem cells (Celavie Biosciences)
Login to view more data
100 Patents (Medical) associated with Allogenic stem cells (Celavie Biosciences)
Login to view more data
100 Deals associated with Allogenic stem cells (Celavie Biosciences)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Parkinson DiseasePhase 1
Mexico
Celavie Biosciences LLCCelavie Biosciences LLC
-
Cerebellar AtaxiaPreclinical
United States
Celavie Biosciences LLCCelavie Biosciences LLC
-
EpilepsyPreclinical
United States
The California State UniversityThe California State University
-
EpilepsyPreclinical
United States
Celavie Biosciences LLCCelavie Biosciences LLC
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free